NAHAR INDS ENT Latest Share Price (NAHARINDUS)
TODAY IN ONE LINE
NAHARINDUS fell 1.6% on light volume, lagging Nifty's 0.3% move.
With a market cap of ₹560.81 Cr., it trades at a P/E of 7.13. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
NAHAR INDS ENT flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 53.4% YoY
- ●Reasonable ValuationTrading at a moderate P/E of 9.9x
- ●High Promoter HoldingPromoters hold 71.2% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 4.9%
Latest NAHAR INDS ENT News
What changed recently?
Recent events, corporate actions, and announcements.
NAHAR INDS ENT valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for NAHAR INDS ENT, framed against the sector median so the premium or discount is obvious at a glance.
NAHAR INDS ENT trades at a P/E of 7.13× and P/B of 0.49×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
NAHAR INDS ENT technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for NAHAR INDS ENT — derived from the latest tape, not yesterday's close.
NAHAR INDS ENT last traded at ₹131.29 with an intraday range of ₹130.5–₹136.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹131.29| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 148.09 | +16.80 | +12.80% |
| R3 | 141.69 | +10.40 | +7.92% |
| R2 | 139.30 | +8.01 | +6.10% |
| R1 | 135.29 | +4.00 | +3.05% |
| PIVOT | 132.90 | 1.61 | 1.22% |
| CURRENT | 131.29 | — | — |
| S1 | 128.89 | -2.40 | -1.83% |
| S2 | 126.50 | -4.79 | -3.65% |
| S3 | 122.49 | -8.80 | -6.70% |
| S4 | 116.09 | -15.20 | -11.57% |
NAHARINDUS is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹131.5–₹136.9
Trading Inside opening range
NAHAR INDS ENT financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for NAHAR INDS ENT — consolidated or standalone — with margins, YoY growth and key ratios inline.
NAHAR INDS ENT reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹560.81 Cr. and reported EPS of ₹5.85.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 1,530 | 1,408 ▼ 7.9% |
| Sales Growth YoY %Derived | 3.96% | -7.95% |
| Other Income | 48 | 100 ▲ 109.1% |
| Total Income | 1,578 | 1,508 ▼ 4.4% |
| 862 | 816 ▼ 5.3% | |
| Gross ProfitDerived | 668 | 592 ▼ 11.3% |
| Gross Margin %Derived | 43.66% | 42.06% |
| 597 | 532 ▼ 10.9% | |
| EBITDA (Operating Profit)Derived | 72 | 61 ▼ 15.4% |
| OPM %Derived | 4.68% | 4.30% |
| 92 | 93 ▲ 1.3% | |
| Profit Before Tax (PBT) | 24 | 66 ▲ 179.7% |
| 6 | 15 ▲ 176.4% | |
| Effective Tax %Derived | 23.51% | 23.24% |
| Total Profit for Period | 18 | 51 ▲ 177.7% |
| Net Profit (Owner's PAT)Derived | 18 | 51 ▲ 177.7% |
| Net Profit Margin %Derived | 1.21% | 3.65% |
| PAT Growth YoY %Derived | 89.98% | 177.71% |
| Earnings Per Share (EPS ₹) | 4.28 | 11.88 ▲ 177.6% |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% |
| Share of Profit from Associates/JVs | 0 | 1 ▲ 67.4% |
| Other Comprehensive Income (Net of Tax) | 1 | 1 ▲ 0.8% |
| Total Expenses (incl. D&A & Interest) | 1,554 | 1,442 ▼ 7.2% |
| Material Cost % of RevenueDerived | 57.82% | 53.15% |
| Employee Cost % of RevenueDerived | 11.88% | 13.25% |
| Other Cost % of RevenueDerived | 27.11% | 24.51% |
| Interest Coverage (x)Derived | 0.52x | 0.24x |
| Period | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,763 | 1,573 ▼ 10.8% | 1,418 ▼ 9.8% | 2,006 ▲ 41.5% | 1,774 ▼ 11.6% | 1,472 ▼ 17.0% | 1,530 ▲ 4.0% | 1,408 ▼ 7.9% | |
| Sales Growth YoY %Derived | — | — | -9.84% | 41.49% | -11.59% | -17.03% | 3.96% | -7.95% | |
| Other Income | 6 | 12 ▲ 100.2% | 8 ▼ 31.2% | 16 ▲ 88.2% | 43 ▲ 173.5% | 31 ▼ 27.7% | 48 ▲ 52.3% | 100 ▲ 109.1% | |
| Total Income | 1,769 | 1,585 ▼ 10.4% | 1,426 ▼ 10.0% | 2,022 ▲ 41.8% | 1,817 ▼ 10.1% | 1,503 ▼ 17.3% | 1,578 ▲ 5.0% | 1,508 ▼ 4.4% | |
1,021 | 901 ▼ 11.8% | 858 ▼ 4.7% | 1,056 ▲ 23.0% | 1,052 ▼ 0.3% | 858 ▼ 18.4% | 862 ▲ 0.5% | 816 ▼ 5.3% | ||
| Gross ProfitDerived | 742 | 672 ▼ 9.4% | 560 ▼ 16.7% | 951 ▲ 69.8% | 722 ▼ 24.1% | 614 ▼ 15.0% | 668 ▲ 8.8% | 592 ▼ 11.3% | |
| Gross Margin %Derived | 42.07% | 42.73% | 39.48% | 47.39% | 40.69% | 41.71% | 43.66% | 42.06% | |
593 | 581 ▼ 2.1% | 466 ▼ 19.7% | 646 ▲ 38.4% | 577 ▼ 10.7% | 557 ▼ 3.4% | 597 ▲ 7.1% | 532 ▼ 10.9% | ||
| EBITDA (Operating Profit)Derived | 148 | 91 ▼ 38.6% | 94 ▲ 2.8% | 305 ▲ 226.3% | 145 ▼ 52.5% | 57 ▼ 60.9% | 72 ▲ 26.4% | 61 ▼ 15.4% | |
| OPM %Derived | 8.41% | 5.79% | 6.60% | 15.21% | 8.18% | 3.85% | 4.68% | 4.30% | |
137 | 136 ▼ 0.6% | 115 ▼ 15.3% | 105 ▼ 8.2% | 85 ▼ 19.5% | 73 ▼ 14.4% | 92 ▲ 26.1% | 93 ▲ 1.3% | ||
| Profit Before Tax (PBT) | 18 | -32 ▼ 282.3% | -13 ▲ 60.2% | 216 ▲ 1770.0% | 101 ▼ 53.1% | 12 ▼ 88.6% | 24 ▲ 104.6% | 66 ▲ 179.7% | |
1 | -8 ▼ 1004.8% | -4 ▲ 53.3% | 59 ▲ 1729.2% | 22 ▼ 62.9% | 2 ▼ 90.6% | 6 ▲ 170.8% | 15 ▲ 176.4% | ||
| Effective Tax %Derived | 4.81% | 23.86% | 28.02% | 27.33% | 21.59% | 17.76% | 23.51% | 23.24% | |
| Total Profit for Period | 18 | -25 ▼ 239.0% | -9 ▲ 64.5% | 157 ▲ 1888.5% | 79 ▼ 49.5% | 10 ▼ 87.7% | 18 ▲ 90.0% | 51 ▲ 177.7% | |
| Net Profit (Owner's PAT)Derived | 18 | -25 ▼ 239.0% | -9 ▲ 64.5% | 157 ▲ 1888.5% | 79 ▼ 49.5% | 10 ▼ 87.7% | 18 ▲ 90.0% | 51 ▲ 177.7% | |
| Net Profit Margin %Derived | 1.01% | -1.57% | -0.62% | 7.82% | 4.47% | 0.66% | 1.21% | 3.65% | |
| PAT Growth YoY %Derived | — | — | 64.47% | 1,888.51% | -49.50% | -87.72% | 89.98% | 177.71% | |
| Earnings Per Share (EPS ₹) | 4.46 | -6.20 ▼ 239.0% | -2.20 ▲ 64.5% | 39.40 ▲ 1890.9% | 18.35 ▼ 53.4% | 2.25 ▼ 87.7% | 4.28 ▲ 90.2% | 11.88 ▲ 177.6% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 8.5% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 1 | 0 ▼ 98.3% | 1 ▲ 3631.2% | 0 ▼ 35.4% | — ▼ 100.0% | 0 | 0 ▲ 78.7% | 1 ▲ 67.4% | |
| Other Comprehensive Income (Net of Tax) | -5 | 2 ▲ 145.8% | 1 ▼ 60.7% | -3 ▼ 385.0% | 1 ▲ 122.9% | 1 ▲ 81.5% | 1 ▲ 18.7% | 1 ▲ 0.8% | |
| Total Expenses (incl. D&A & Interest) | 1,751 | 1,617 ▼ 7.6% | 1,439 ▼ 11.0% | 1,807 ▲ 25.5% | 1,716 ▼ 5.0% | 1,492 ▼ 13.1% | 1,554 ▲ 4.2% | 1,442 ▼ 7.2% | |
| Material Cost % of RevenueDerived | 58.38% | 50.79% | 51.26% | 56.72% | 51.96% | 58.38% | 57.82% | 53.15% | |
| Employee Cost % of RevenueDerived | 10.52% | 11.23% | 9.18% | 8.13% | 9.35% | 11.33% | 11.88% | 13.25% | |
| Other Cost % of RevenueDerived | 23.14% | 25.71% | 23.71% | 24.05% | 23.17% | 26.53% | 27.11% | 24.51% | |
| Interest Coverage (x)Derived | 1.17x | 0.31x | 0.63x | 4.59x | 2.57x | 0.38x | 0.52x | 0.24x |
NAHAR INDS ENT segment analysis : revenue and profit mix.
Disclosed business segments at NAHAR INDS ENT with their share of revenue and profit, switchable between consolidated and standalone reporting.
NAHAR INDS ENT discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for NAHAR INDS ENT.
Our AI distills the core fundamental drivers supporting NAHAR INDS ENT, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
NAHAR INDS ENT's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 9 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.15. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
NAHAR INDS ENT peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — NAHAR INDS ENT is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
NAHAR INDS ENT chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for NAHAR INDS ENT — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
NAHAR INDS ENT delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for NAHAR INDS ENT over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in NAHAR INDS ENT stood at 72.0% of traded volume, against a 20-day average of 60.4%.
NAHAR INDS ENT announcements: results, concalls, ratings, M&A.
Filings NAHAR INDS ENT sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
NAHAR INDS ENT files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 57 documents below.
Credit Rating
Nahar Industrial Enterprises Limited has informed the Exchange about Credit Rating
Record Date
Nahar Industrial Enterprises Limited has informed the Exchange that Record date for the purpose of Meeting is 23-Sep-2026 to 29.09.2026
Copy of Newspaper Publication
Nahar Industrial Enterprises Limited has informed the Exchange about Copy of Newspaper Publication
General Updates
Nahar Industrial Enterprises Limited has informed the Exchange about General Updates - Intimation under Regulation 36(1) (b) of SEBI (LODR)…
Copy of Newspaper Publication
Nahar Industrial Enterprises Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
NAHAR INDS ENT dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue NAHAR INDS ENT has declared, sequenced by announce and record date.
NAHAR INDS ENT corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About NAHAR INDS ENT: business, sector, key facts.
What NAHAR INDS ENT does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
NAHAR INDS ENT operates in the Other Textile Products industry under the Textiles sector, listed as NSE: NAHARINDUS, BSE: 519136.
Nahar Industrial Enterprises Limited (NIEL) is an Indian company primarily operating in the textile and sugar industries. Established in 1983 and formerly known as Oswal Fats & Oils Limited, the company underwent a name change in 1994 to reflect its evolving business focus. NIEL's headquarters are located in Ludhiana, India, a significant center for textile manufacturing in the country.
NIEL's business operations are structured into three segments: Textile, Sugar, and Others. The Textile segment constitutes a core part of the company's activities. Within this segment, NIEL produces and offers a range of fabrics and yarns to the market. The precise types and specifications of these products are not detailed in the provided information, but the presence of a dedicated textile segment highlights its importance to the company's overall revenue and strategic direction.
The Sugar segment indicates NIEL's involvement in the sugar production and processing industry. The specifics of this segment, such as the scale of operations, geographical locations of facilities, and brands marketed are not specified. However, its inclusion as a separate operating segment signifies a significant commitment to this sector within NIEL's overall business portfolio. It likely involves the cultivation of sugarcane, processing of raw sugar, and the sale and distribution of refined sugar products.
The "Others" segment encompasses any remaining business activities not explicitly categorized under Textile or Sugar. The nature of these activities is unknown without further information. This segment could potentially include ancillary businesses supporting the core textile and sugar operations, investments in other sectors, or other revenue-generating activities. Further details about this segment's contribution to the company's overall performance are required for a complete understanding of NIEL's overall business model.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AKSHAR SPINTEX (AKSHAR) Share PricePeer
- ALOK INDUSTRIES (ALOKINDS) Share PricePeer
- AMBIKA COTTON MILL (AMBIKCO) Share PricePeer
- ASHIMA (ASHIMASYN) Share PricePeer
- AXITA COTTON (AXITA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about NAHAR INDS ENT (NAHARINDUS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of NAHAR INDS ENT (NAHARINDUS)?
The current share price of NAHAR INDS ENT (NAHARINDUS) is ₹131.29. Today, the stock has declined by ₹2.18 (1.63%), trading in a range of ₹130.50 to ₹136.90. The stock opened at ₹131.50 with a trading volume of 6,308 shares.
02Is NAHAR INDS ENT stock a good investment for long-term?
NAHAR INDS ENT can be considered for long-term investment based on several factors. The company has a market capitalization of ₹560.81 Cr., P/E ratio of 7.13, ROE of 4.92%, and ROCE of 4.91%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of NAHAR INDS ENT stock?
The 52-week high price of NAHAR INDS ENT (NAHARINDUS) is ₹154.00, while the 52-week low is ₹83.05. Currently trading at ₹131.29, the stock is 58.09% above its 52-week low and 14.75% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy NAHAR INDS ENT stock at the current price?
Whether to buy NAHAR INDS ENT stock at ₹131.29 depends on multiple factors. The stock is currently trading with a P/E ratio of 7.13 and P/B ratio of 0.49. Today's performance shows a loss of 1.63%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of NAHAR INDS ENT and when is the next dividend?
NAHAR INDS ENT offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹131.29, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of NAHAR INDS ENT?
NAHAR INDS ENT's key financial metrics include: P/E Ratio: 7.13, P/B Ratio: 0.49, ROE: 4.92%, ROCE: 4.91%, Dividend Yield: 0%, EPS: ₹5.85, Book Value: ₹241.40, and Debt-to-Equity: 0.65. The company's market cap stands at ₹560.81 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is NAHAR INDS ENT stock performing today in the market?
NAHAR INDS ENT stock opened at ₹131.50 and is currently trading at ₹131.29, showing a decline of ₹2.18 (1.63%). The intraday high is ₹136.90 and low is ₹130.50. The trading volume stands at 6,308 shares, indicating moderate market participation today.
08What is the P/E ratio of NAHAR INDS ENT and what does it indicate?
NAHAR INDS ENT has a Price-to-Earnings (P/E) ratio of 7.13, which means investors are willing to pay 7.13 for every ₹1 of earnings. With an EPS of ₹5.85, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about NAHAR INDS ENT (NAHARINDUS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.